According to a new market research from Percepta, US life scientists anticipate $7.4 billion in new NIH grant funds by 2010
Carlsbad, CA – August 12, 2009 – Percepta Associates announced today the release of a new complimentary market research report Life Science Research Funding Optimism In The United States: A Researcher’s Perspective. The report details the anticipated impact of the American Recovery and Reinvestment Act of 2009 (ARRA) on life science research funding and biotools companies in America. The report finds that funding optimism among US life scientists is increasing significantly through 2010 with greater than 80% of the approximately $9 billion, supplied through the ARRA, to be distributed through life science research funding grants administered by the National Institutes of Health (NIH) over the next 18 months. Percepta reports this new funding will likely result in higher short term revenues for research tools companies serving US laboratories as the funding is partly used to pay for new research consumables and equipment. This free report is available for download at: www.perceptaassociates.com/publications compliments of Percepta Associates.
Founded in 2005 in Carlsbad, California Percepta Associates is a specialized consultancy providing expert market research, strategic business planning, portfolio management, product and corporate branding and marketing communications services to the life sciences research supply industry. Percepta also publishes the Life Science Dashboard™ series of market research reports focused on delivering segment specific key market indicators at a glance. For more information visit www.perceptaassociates.com or call 760.597.9236.
Percepta Associates Inc.
Phone: 760 597 9236